Global at-home vaginal ph test kit demand is anticipated to be valued at US$ 100 Million in 2022, forecast to grow at a CAGR of 5.76% to be valued at US$ 175 Million from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 95 Million |
| Expected Market Value (2022) | US$ 100 Million |
| Anticipated Forecast Value (2032) | US$ 175 Million |
| Projected Growth Rate (2022 to 2032) | 5.76% CAGR |
The pH of vaginal secretion is measured using at-home vaginal pH test kits. The At-Home Vaginal pH Test is a qualitative test used to determine an unbalanced pH level of vaginal secretion. In the case of unusual vaginal symptoms such as unpleasant odor, burning, itching, or unusual discharge, an at-home vaginal pH test is performed.
At-home vaginal pH tests can help determine whether a patient is experiencing unusual vaginal symptoms. The at-home vaginal pH test, on the other hand, will not aid in the diagnosis of group B streptococcus HIV, gonorrhea, herpes, syphilis, or Chlamydia.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The At-Home Vaginal pH Test detects vaginal infections early. The pH of the vaginal fluid should be between 3.8 and 4.5. If a vaginal pH of 5.0 or higher is detected using at-home vaginal pH test kits, it indicates the presence of either trichomoniasis or bacterial vaginosis.
A pH less than 3.5, on the other hand, indicates the presence of yeast infection. Furthermore, at-home vaginal pH test kits are a cost-effective option for detecting vaginitis at home without visiting a doctor. Furthermore, the at-home vaginal pH test kit is useful for maintaining the pH balance of the vaginal area, early diagnosis of the disorder related to vaginal flora, prevention of vaginal infection, greater safety during pregnancy, and monitoring the effectiveness of any treatment. These factors and benefits are expected to drive the market for at-home vaginal pH test kits forward.
If the woman has recently had intercourse or is on her period, the results of at-home vaginal pH test kits may be inaccurate. Even after using an at-home vaginal pH test, most patients should still see a doctor or a gynecologist to get the most accurate diagnosis. These factors are expected to have a negative impact on the growth of the market for at-home vaginal pH test kits.
Principal Consultant
Asia Pacific is expected to be the largest market for At-Home Vaginal pH Test Kit during the forecast period owing to increasing awareness about vaginal infections as well as hygiene among the women in this region. The growing practice of self-testing is expected to augment the At-Home Vaginal pH Test Kit market. The region is forecast to surge in the upcoming years.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for the At-Home Vaginal pH Test Kit, with Germany expected to steer the bulk of all regional growth. Extensive applications in the pharmaceutical industry are keeping sales of At-Home Vaginal pH Test Kit afloat across Germany.
Countries such as Poland, Belgium, the United Kingdom, and the Czech Republic are all also generating high demand for At-Home Vaginal pH Test Kit, as these regions are witnessing an increasing awareness of vaginal hygiene.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Home test, Bayer AG, Prestige Consumer Healthcare, Inc., GRÜNSPECHT Naturprodukte GmbH, Vagisil, and Dream Future Innovation are some of the market participants identified across the value chain in the Global At-Home Vaginal pH Test kit market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.76% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global At-Home Vaginal pH Test Kit market to expand at a 5.76% value CAGR by 2032.
Asia Pacific is expected to be the most opportunistic At-Home Vaginal pH Test Kit market.
Home test, Bayer AG, Prestige Consumer Healthcare, Inc, and Dream Future Innovation are some prominent At-Home Vaginal pH Test Kit manufacturers.
1. Executive Summary | At-Home Vaginal pH Test Kit Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032 5.3.1. Trichomoniasis 5.3.2. Bacterial Vaginosis 5.3.3. Yeast Infection 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032 6.3.1. Hospital Pharmacies 6.3.2. Retail Pharmacies 6.3.3. Online Pharmacies 6.3.4. Fertilization Centers 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Indication 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Indication 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Mexico 9.2.1.2. Brazil 9.2.1.3. Rest of Latin America 9.2.2. By Indication 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Indication 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. United Kingdom 10.2.1.5. Spain 10.2.1.6. BENELUX 10.2.1.7. Russia 10.2.1.8. Rest of Europe 10.2.2. By Indication 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Indication 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. ASEAN 12.2.1.3. Australia and New Zealand 12.2.1.4. Rest of South Asia & Pacific 12.2.2. By Indication 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. Turkey 13.2.1.3. South Africa 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Indication 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Indication 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Indication 14.1.2.2. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Indication 14.2.2.2. By Distribution Channel 14.3. Mexico 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Indication 14.3.2.2. By Distribution Channel 14.4. Brazil 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Indication 14.4.2.2. By Distribution Channel 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Indication 14.5.2.2. By Distribution Channel 14.6. Italy 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Indication 14.6.2.2. By Distribution Channel 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Indication 14.7.2.2. By Distribution Channel 14.8. United Kingdom 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Indication 14.8.2.2. By Distribution Channel 14.9. Spain 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Indication 14.9.2.2. By Distribution Channel 14.10. BENELUX 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Indication 14.10.2.2. By Distribution Channel 14.11. Russia 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Indication 14.11.2.2. By Distribution Channel 14.12. China 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Indication 14.12.2.2. By Distribution Channel 14.13. Japan 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Indication 14.13.2.2. By Distribution Channel 14.14. South Korea 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Indication 14.14.2.2. By Distribution Channel 14.15. India 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Indication 14.15.2.2. By Distribution Channel 14.16. ASIAN 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Indication 14.16.2.2. By Distribution Channel 14.17. Australia and New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Indication 14.17.2.2. By Distribution Channel 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Indication 14.18.2.2. By Distribution Channel 14.19. Turkey 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Indication 14.19.2.2. By Distribution Channel 14.20. South Africa 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Indication 14.20.2.2. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Indication 15.3.3. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Bayer AG 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Hometest 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Prestige Consumer Healthcare, Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Vagisil 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. AdvaCare 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Pee Safe 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. GRÜNSPECHT Naturprodukte GmbH 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Savyon Diagnostics 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Sanotest 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. AAA Surgical Pharma 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Setia Scientific Solution 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Healthcare
February 2022
REP-GB-607
October 2023
183 pages
Healthcare
December 2021
REP-GB-452
September 2023
239 pages
Explore Healthcare Insights
View Reports
At-Home Vaginal pH Test Kit Market
